DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Stein CA, Levin R, Given R. et al.
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: the STAAR study.
Urol Oncol 2018;
36 (02) 81.e9-81.e16
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.